Average Co-Inventor Count = 5.46
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ucb Biopharma Sprl (9 from 138 patents)
2. Katholieke Universiteit Leuven, Ku Leuven R&d (5 from 238 patents)
3. Ucbbiopharma Srl (3 from 109 patents)
4. Other (2 from 832,680 patents)
5. Celltech Therapeutics Limited (2 from 81 patents)
6. Ucb Pharma, S.a. (1 from 179 patents)
7. Katholieke Universiteit Leuven (345 patents)
17 patents:
1. 12391688 - Imidazopyridine derivatives as IL-17 modulators
2. 11472794 - Fused imidazole derivatives as IL-17 modulators
3. RE48622 - Therapeutically active pyrazolo-pyrimidine derivatives
4. 10450320 - Hexahydropyrazinotriazinone derivatives as kinase inhibitors
5. 10087180 - Pyrazolo-pyridine derivatives as kinase inhibitors
6. 10004737 - Fused imidazole and pyrazole derivatives as modulators of TNF activity
7. 10000497 - Fused bicyclic heteroaromatic derivatives as kinase inhibitors
8. 9969748 - Fused bicyclic heteroaromatic derivatives as kinase inhibitors
9. 9815797 - Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
10. 9714248 - Therapeutically active pyrazolo-pyrimidine derivatives
11. 9550737 - TNF -α modulating benzimidazoles
12. 9382263 - Therapeutically active oxazoline derivatives
13. 9309243 - Imidazopyridine derivatives as modulators of TNF activity
14. 9227984 - Therapeutically active fused pyrimidine derivatives
15. 9096614 - Therapeutically active thiazolo-pyrimidine derivatives